| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/23/2007 | CN1966044A Capsule for treating disease caused by emotional disorder |
| 05/23/2007 | CN1966041A Chinese medicinal formulation for treating depression |
| 05/23/2007 | CN1966038A Drink for decomposing alcohol |
| 05/23/2007 | CN1966035A Chinese medicinal formulation for treating children's hyperkinetic syndrome |
| 05/23/2007 | CN1966024A Pharmaceutical composition for treating diabetes complication and preparation process thereof |
| 05/23/2007 | CN1966010A Medicament for opening orifices and tranquilizing mind for treating wind syndrome caused by excessive heat of infant |
| 05/23/2007 | CN1966006A Novel application of highland barley extract |
| 05/23/2007 | CN1966004A Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae |
| 05/23/2007 | CN1965996A Preparation method of Chinese medicinal capsule for treating apoplexy |
| 05/23/2007 | CN1965972A Medicinal decoction for treating blood deficiency type insomnia and method for preparing same |
| 05/23/2007 | CN1965950A Tincture for treating muscle and joint pain |
| 05/23/2007 | CN1965919A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965860A Acupoints applied medicament for treating insomnia and preparation process thereof |
| 05/23/2007 | CN1965852A Aloeresin D and effective component, preparation process, pharmaceutical composition and use thereof |
| 05/23/2007 | CN1965840A Method for preventing weight increase caused by antipsychotic |
| 05/23/2007 | CN1965822A Sustained release formulation of bilobalide-B and preparation process thereof |
| 05/23/2007 | CN1965735A Medicinal pillow filled with tartary buckwheat shell and preparation process thereof |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317292C Anti-sense nucleic acid for stopping drug addiction |
| 05/23/2007 | CN1317280C Novel diazabicyclic aryl derivatives |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317276C Indolylpiperidine compound and preparation process and use thereof |
| 05/23/2007 | CN1317030C Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 05/23/2007 | CN1317027C Chinese medicine for treating depression |
| 05/23/2007 | CN1316995C Application of 'Qingkailing' in preparing medication for treating diseases in nerve and immunity |
| 05/23/2007 | CN1316994C Production of containing bupleurum root, seed of spine date and soybean isoflavone for improving sleeping, and preparation method thereof |
| 05/23/2007 | CN1316976C Use of kaempferol-3-O-glubulariacitrin in preparing medicine for senile dementia |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/23/2007 | CN1316972C Anti-cancer analgetic preparation |
| 05/23/2007 | CN1316959C Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method |
| 05/22/2007 | US7220875 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220866 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 05/22/2007 | US7220862 Calcitonin gene related peptide receptor antagonists |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220767 Pharmaceutical formulations containing zolmitriptan |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 05/22/2007 | US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster |
| 05/22/2007 | US7220741 As cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters, for therapy of central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders |
| 05/22/2007 | US7220740 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2275353C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2162232C Cerebration improver |
| 05/22/2007 | CA2157579C Heterocyclic compounds, their use and preparation |
| 05/18/2007 | WO2007056582A1 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 05/18/2007 | WO2007056497A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | WO2007056496A1 Oxazole and thiazole ppar modulator |
| 05/18/2007 | WO2007056117A1 Antineoplastic combinations of temsirolimus and sunitinib malate |
| 05/18/2007 | WO2007056046A1 P2x7 receptor antagonists and methods of use |
| 05/18/2007 | WO2007055928A1 5-membered ring metanicotine analogs |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007055044A1 Promoter for recovery from anesthesia |
| 05/18/2007 | WO2007054814A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | WO2007054778A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 05/18/2007 | WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | WO2007054531A1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/18/2007 | WO2007054444A2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 05/18/2007 | WO2007054436A2 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists |
| 05/18/2007 | WO2007054378A1 Anti-misuse microparticulate oral pharmaceutical form |
| 05/18/2007 | WO2007054302A1 Diaryl ureas for treating diabetic neuropathy |
| 05/18/2007 | WO2007036715A3 Compounds which have activity at m1 receptor and their uses in medicine |
| 05/18/2007 | WO2007034282A3 Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 05/18/2007 | WO2007011647A3 Inhibitors of mitotic kinesin ksp |
| 05/18/2007 | WO2006096405A3 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 05/18/2007 | WO2006036278A8 THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF |
| 05/18/2007 | WO2006025057A8 Use of il-6 in vascular complications |
| 05/18/2007 | CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | CA2629376A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | CA2629237A1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2628936A1 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists |
| 05/18/2007 | CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | CA2628881A1 Diaryl urea for treating diabetic neuropathy |
| 05/18/2007 | CA2628875A1 Diaryl ureas for treating diabetic neuropathy |
| 05/18/2007 | CA2628667A1 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 05/18/2007 | CA2628441A1 Compounds for modulating trpv3 function |
| 05/18/2007 | CA2627114A1 P2x7 receptor antagonists and methods of use |
| 05/18/2007 | CA2627089A1 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 05/18/2007 | CA2627058A1 Anti-misuse microparticulate oral pharmaceutical form |
| 05/18/2007 | CA2626446A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | CA2626443A1 Oxazole and thiazole ppar modulators |